149 related articles for article (PubMed ID: 15778454)
1. Centaurin-alpha 1, an ADP-ribosylation factor 6 GTPase activating protein, inhibits beta 2-adrenoceptor internalization.
Lawrence J; Mundell SJ; Yun H; Kelly E; Venkateswarlu K
Mol Pharmacol; 2005 Jun; 67(6):1822-8. PubMed ID: 15778454
[TBL] [Abstract][Full Text] [Related]
2. Identification of centaurin-alpha1 as a potential in vivo phosphatidylinositol 3,4,5-trisphosphate-binding protein that is functionally homologous to the yeast ADP-ribosylation factor (ARF) GTPase-activating protein, Gcs1.
Venkateswarlu K; Oatey PB; Tavaré JM; Jackson TR; Cullen PJ
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):359-63. PubMed ID: 10333475
[TBL] [Abstract][Full Text] [Related]
3. The arf6 GAP centaurin alpha-1 is a neuronal actin-binding protein which also functions via GAP-independent activity to regulate the actin cytoskeleton.
Thacker E; Kearns B; Chapman C; Hammond J; Howell A; Theibert A
Eur J Cell Biol; 2004 Oct; 83(10):541-54. PubMed ID: 15679100
[TBL] [Abstract][Full Text] [Related]
4. PI-3-kinase-dependent membrane recruitment of centaurin-alpha2 is essential for its effect on ARF6-mediated actin cytoskeleton reorganisation.
Venkateswarlu K; Brandom KG; Yun H
J Cell Sci; 2007 Mar; 120(Pt 5):792-801. PubMed ID: 17284522
[TBL] [Abstract][Full Text] [Related]
5. Centaurin-alpha1 is an in vivo phosphatidylinositol 3,4,5-trisphosphate-dependent GTPase-activating protein for ARF6 that is involved in actin cytoskeleton organization.
Venkateswarlu K; Brandom KG; Lawrence JL
J Biol Chem; 2004 Feb; 279(8):6205-8. PubMed ID: 14625293
[TBL] [Abstract][Full Text] [Related]
6. Centaurin-alpha1 interacts directly with kinesin motor protein KIF13B.
Venkateswarlu K; Hanada T; Chishti AH
J Cell Sci; 2005 Jun; 118(Pt 11):2471-84. PubMed ID: 15923660
[TBL] [Abstract][Full Text] [Related]
7. ARF6 activation by Galpha q signaling: Galpha q forms molecular complexes with ARNO and ARF6.
Giguère P; Rochdi MD; Laroche G; Dupré E; Whorton MR; Sunahara RK; Claing A; Dupuis G; Parent JL
Cell Signal; 2006 Nov; 18(11):1988-94. PubMed ID: 16650966
[TBL] [Abstract][Full Text] [Related]
8. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
[TBL] [Abstract][Full Text] [Related]
9. ADP-ribosylation factor 6 regulates mu-opioid receptor trafficking and signaling via activation of phospholipase D2.
Rankovic M; Jacob L; Rankovic V; Brandenburg LO; Schröder H; Höllt V; Koch T
Cell Signal; 2009 Dec; 21(12):1784-93. PubMed ID: 19666113
[TBL] [Abstract][Full Text] [Related]
10. ARF6 regulates angiotensin II type 1 receptor endocytosis by controlling the recruitment of AP-2 and clathrin.
Poupart ME; Fessart D; Cotton M; Laporte SA; Claing A
Cell Signal; 2007 Nov; 19(11):2370-8. PubMed ID: 17719203
[TBL] [Abstract][Full Text] [Related]
11. beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis.
Claing A; Chen W; Miller WE; Vitale N; Moss J; Premont RT; Lefkowitz RJ
J Biol Chem; 2001 Nov; 276(45):42509-13. PubMed ID: 11533043
[TBL] [Abstract][Full Text] [Related]
12. Regulation of G protein-coupled receptor endocytosis by ARF6 GTP-binding proteins.
Claing A
Biochem Cell Biol; 2004 Dec; 82(6):610-7. PubMed ID: 15674428
[TBL] [Abstract][Full Text] [Related]
13. The Arf6 GTPase-activating proteins ARAP2 and ACAP1 define distinct endosomal compartments that regulate integrin α5β1 traffic.
Chen PW; Luo R; Jian X; Randazzo PA
J Biol Chem; 2014 Oct; 289(44):30237-30248. PubMed ID: 25225293
[TBL] [Abstract][Full Text] [Related]
14. Rab35 regulates Arf6 activity through centaurin-β2 (ACAP2) during neurite outgrowth.
Kobayashi H; Fukuda M
J Cell Sci; 2012 May; 125(Pt 9):2235-43. PubMed ID: 22344257
[TBL] [Abstract][Full Text] [Related]
15. Assays and properties of the ArfGAPs, AMAP1 and AMAP2, in Arf6 function.
Hashimoto S; Hashimoto A; Yamada A; Onodera Y; Sabe H
Methods Enzymol; 2005; 404():216-31. PubMed ID: 16413272
[TBL] [Abstract][Full Text] [Related]
16. Role of ARF6 in internalization of metal-binding proteins, metallothionein and transferrin, and cadmium-metallothionein toxicity in kidney proximal tubule cells.
Wolff NA; Lee WK; Abouhamed M; Thévenod F
Toxicol Appl Pharmacol; 2008 Jul; 230(1):78-85. PubMed ID: 18353411
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological sequestration of a chimeric beta 3/beta 2 adrenergic receptor occurs without a corresponding amount of receptor internalization.
Mostafapour S; Kobilka BK; von Zastrow M
Recept Signal Transduct; 1996; 6(3-4):151-63. PubMed ID: 9259050
[TBL] [Abstract][Full Text] [Related]
18. Trafficking of beta2-adrenergic receptors: insulin and beta-agonists regulate internalization by distinct cytoskeletal pathways.
Shumay E; Gavi S; Wang HY; Malbon CC
J Cell Sci; 2004 Feb; 117(Pt 4):593-600. PubMed ID: 14709719
[TBL] [Abstract][Full Text] [Related]
19. The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization.
Mukherjee S; Gurevich VV; Jones JC; Casanova JE; Frank SR; Maizels ET; Bader MF; Kahn RA; Palczewski K; Aktories K; Hunzicker-Dunn M
Proc Natl Acad Sci U S A; 2000 May; 97(11):5901-6. PubMed ID: 10811902
[TBL] [Abstract][Full Text] [Related]
20. Arf6 negatively controls the rapid recycling of the β2 adrenergic receptor.
Macia E; Partisani M; Paleotti O; Luton F; Franco M
J Cell Sci; 2012 Sep; 125(Pt 17):4026-35. PubMed ID: 22611259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
